SMTSahajanand Medical Technologies Limited
Convert to ideaHealthcare · Healthcare Supplies · CRISIL: A- (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeMomentum from moving averages, Supertrend and RSI.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
Forensic screen of the latest filings
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs undefined undefined
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹373 Cr | ₹26 Cr | 11.95% | 7.09% | ₹2.63 | 6.9x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Healthcare Supplies
Compare with peers →The company manufactures Class III and Class C/D medical devices for vascular and structural heart interventions, including coronary stents, balloons, TAVI devices, and occluders. It operates two R&D centers in India and Thailand and distributes its products to customers in 65 to 77 countries.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.